Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CNCE

Concert Pharmaceuticals (CNCE) Stock Price, News & Analysis

Concert Pharmaceuticals logo

About Concert Pharmaceuticals Stock (NASDAQ:CNCE)

Advanced Chart

Key Stats

Today's Range
$8.37
$8.37
50-Day Range
$8.33
$8.40
52-Week Range
$2.66
$8.55
Volume
N/A
Average Volume
2.97 million shs
Market Capitalization
$401.26 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CNCE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Concert Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

CNCE Stock News Headlines

"I'm risking my reputation on this"
Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the same signals. They're positioning themselves for something unprecedented. And after 17 million podcast downloads and over 600 insider interviews, I finally connected all the dots… What I discovered was so explosive, so potentially life-changing, that I had to put it all in a book.
See More Headlines

CNCE Stock Analysis - Frequently Asked Questions

Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) posted its quarterly earnings results on Tuesday, November, 9th. The biotechnology company reported ($0.78) earnings per share for the quarter, topping analysts' consensus estimates of ($0.81) by $0.03. The biotechnology company had revenue of $0.54 million for the quarter, compared to analysts' expectations of $0.25 million.

Based on aggregate information from My MarketBeat watchlists, some other companies that Concert Pharmaceuticals investors own include Intel (INTC), Bristol Myers Squibb (BMY), Gilead Sciences (GILD), Global Blood Therapeutics (GBT), Micron Technology (MU), Pfizer (PFE) and NVIDIA (NVDA).

Company Calendar

Last Earnings
11/09/2021
Today
7/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:CNCE
CIK
1367920
Employees
64
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($3.21)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$80.05 million
Net Margins
N/A
Pretax Margin
-300,735.69%
Return on Equity
-109.43%
Return on Assets
-76.65%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
9.03
Quick Ratio
9.03

Sales & Book Value

Annual Sales
$32.58 million
Price / Sales
12.32
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$3.24 per share
Price / Book
2.58

Miscellaneous

Outstanding Shares
47,940,000
Free Float
42,507,000
Market Cap
$401.26 million
Optionable
Optionable
Beta
0.52

Social Links

10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:CNCE) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners